Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice
Background: Population mean changes from clinical trials are difficult to apply to individuals in clinical practice. Responder analysis may be better, but need validating for levels of response and treatment duration. Methods: The numbers of patients with pain relief over baseline (≥15%, ≥30%, ≥50%,...
Main Authors: | Moore, R, Moore, O, Derry, S, Peloso, P, Gammaitoni, A, Wang, H |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2010
|
Subjects: |
Similar Items
-
Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.
by: Moore, R, et al.
Published: (2010) -
Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports
by: Moore, R, et al.
Published: (2008) -
Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores
by: Moore, R, et al.
Published: (2008) -
Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen/paracetamol combinations after third molar extraction
by: Moore, R, et al.
Published: (2011) -
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
by: Moore, R, et al.
Published: (2006)